cgp 12177 has been researched along with Myocardial Infarction in 1 studies
CGP 12177 : A benzimidazole that is benzimidazol-2-one substituted at position 4 by a 3-(tert-butylamino)-2-hydroxypropoxy group.
Myocardial Infarction: NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gaemperli, O | 1 |
| Liga, R | 1 |
| Spyrou, N | 1 |
| Rosen, SD | 1 |
| Foale, R | 1 |
| Kooner, JS | 1 |
| Rimoldi, OE | 1 |
| Camici, PG | 1 |
1 other study available for cgp 12177 and Myocardial Infarction
| Article | Year |
|---|---|
Myocardial beta-adrenoceptor down-regulation early after infarction is associated with long-term incidence of congestive heart failure.
Topics: Adrenergic beta-Antagonists; Adult; Coronary Circulation; Down-Regulation; Female; Heart; Heart Fail | 2010 |